Active Ingredient: | APIXABAN |
Dosage Form;Route: | TABLET;ORAL |
Proprietary Name: | ELIQUIS |
Applicant: | BRISTOL MYERS SQUIBB |
Strength: | 2.5MG |
Application Number: | N202155 |
Product Number: | 001 |
Approval Date: | Dec 28, 2012 |
Reference Listed Drug | No |
RX/OTC/DISCN: | RX |
TE Code: | |
Patent and Exclusivity Info for this product: | View |
Active Ingredient: | APIXABAN |
Dosage Form;Route: | TABLET;ORAL |
Proprietary Name: | ELIQUIS |
Applicant: | BRISTOL MYERS SQUIBB |
Strength: | 5MG |
Application Number: | N202155 |
Product Number: | 002 |
Approval Date: | Dec 28, 2012 |
Reference Listed Drug | Yes |
RX/OTC/DISCN: | RX |
TE Code: | |
Patent and Exclusivity Info for this product: | View |
Appl No | Prod No | Patent No | Patent Expiration | Drug Substance Claim | Drug Product Claim | Patent Use Code | Delist Requested |
N202155 | 002 | 6413980 | Dec 22, 2019 | Y | Y | U - 1200 | |
N202155 | 002 | 6967208 | Feb 3, 2023 | Y | Y | U - 1200 | |
N202155 | 002 | 6967208 | Feb 3, 2023 | Y | Y | U - 1323 | |
Appl No | Prod No | Exclusivity Code | Exclusivity Expiration |
N202155 | 002 | NCE | Dec 28, 2017 |
本文发布于:2024-09-25 02:31:44,感谢您对本站的认可!
本文链接:https://www.17tex.com/tex/3/459900.html
版权声明:本站内容均来自互联网,仅供演示用,请勿用于商业和其他非法用途。如果侵犯了您的权益请与我们联系,我们将在24小时内删除。
留言与评论(共有 0 条评论) |